Cybulski et al. sequenced the coding region of CHEK2 using genomic DNA from 140 Polish prostate patients and investigated a role of three variants, including CHEK2∗1100delC in prostate cancer risk. The gene discussed is CHEK2; the disease is prostate cancer.